Last update 17 Apr 2025

Bifonazole/Triamcinolone Acetonide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
CYP51A1 x GR
Action
inhibitors, agonists
Mechanism
CYP51A1 inhibitors(Cytochrome P450 51 inhibitors), GR agonists(Glucocorticoid receptor agonists)
Therapeutic Areas
Infectious DiseasesSkin and Musculoskeletal DiseasesUrogenital Diseases
Active Indication
Candidiasis, VulvovaginalTinea corporistinea cruris+ [3]
Inactive Indication-
Originator Organization-
Active Organization
Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC22H18N2
InChIKeyOCAPBUJLXMYKEJ-UHFFFAOYSA-N
CAS Registry60628-96-8
View All Structures (2)

Related

1
Clinical Trials associated with Bifonazole/Triamcinolone Acetonide
CTR20131282
/ Active, not recruitingPhase 3
联苯苄唑曲安奈德乳膏治疗炎症性浅表皮肤真菌病有效性和安全性的多中心、随机双盲、平行对照临床试验
[Translation] A multicenter, randomized, double-blind, parallel controlled clinical trial on the efficacy and safety of triamcinolone acetonide cream in the treatment of inflammatory superficial dermatophytosis
100 Clinical Results associated with Bifonazole/Triamcinolone Acetonide
Login to view more data
100 Translational Medicine associated with Bifonazole/Triamcinolone Acetonide
Login to view more data
100 Patents (Medical) associated with Bifonazole/Triamcinolone Acetonide
Login to view more data
100 Deals associated with Bifonazole/Triamcinolone Acetonide
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Candidiasis, VulvovaginalPhase 3
China
Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
10 Dec 2010
Tinea corporisPhase 3
China
Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
10 Dec 2010
tinea crurisPhase 3
China
Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
10 Dec 2010
Tinea ManusPhase 3
China
Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
10 Dec 2010
Tinea PedisPhase 3
China
Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
10 Dec 2010
Tinea VersicolorPhase 3
China
Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
10 Dec 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free